APA (7th ed.) Citation

Dela Cruz Chuh, J., Go, M., Chen, Y., Guo, J., Rafidi, H., Mandikian, D., . . . Agard, N. J. (2021). Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response. mAbs, 13(1), 1862452. https://doi.org/10.1080/19420862.2020.1862452

Chicago Style (17th ed.) Citation

Dela Cruz Chuh, Josefa, et al. "Preclinical Optimization of Ly6E-targeted ADCs for Increased Durability and Efficacy of Anti-tumor Response." MAbs 13, no. 1 (2021): 1862452. https://doi.org/10.1080/19420862.2020.1862452.

MLA (9th ed.) Citation

Dela Cruz Chuh, Josefa, et al. "Preclinical Optimization of Ly6E-targeted ADCs for Increased Durability and Efficacy of Anti-tumor Response." MAbs, vol. 13, no. 1, 2021, p. 1862452, https://doi.org/10.1080/19420862.2020.1862452.